1. Home
  2. MFC vs KTTA Comparison

MFC vs KTTA Comparison

Compare MFC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFC
  • KTTA
  • Stock Information
  • Founded
  • MFC 1887
  • KTTA 2020
  • Country
  • MFC Canada
  • KTTA United States
  • Employees
  • MFC N/A
  • KTTA N/A
  • Industry
  • MFC Life Insurance
  • KTTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFC Finance
  • KTTA Health Care
  • Exchange
  • MFC Nasdaq
  • KTTA Nasdaq
  • Market Cap
  • MFC 49.3B
  • KTTA 5.5M
  • IPO Year
  • MFC 1999
  • KTTA 2021
  • Fundamental
  • Price
  • MFC $30.47
  • KTTA $0.68
  • Analyst Decision
  • MFC Buy
  • KTTA
  • Analyst Count
  • MFC 1
  • KTTA 0
  • Target Price
  • MFC $51.00
  • KTTA N/A
  • AVG Volume (30 Days)
  • MFC 2.3M
  • KTTA 142.8K
  • Earning Date
  • MFC 08-06-2025
  • KTTA 08-12-2025
  • Dividend Yield
  • MFC 3.93%
  • KTTA N/A
  • EPS Growth
  • MFC 14.95
  • KTTA N/A
  • EPS
  • MFC 1.85
  • KTTA N/A
  • Revenue
  • MFC $20,887,744,800.00
  • KTTA N/A
  • Revenue This Year
  • MFC $35.15
  • KTTA N/A
  • Revenue Next Year
  • MFC $5.64
  • KTTA N/A
  • P/E Ratio
  • MFC $16.51
  • KTTA N/A
  • Revenue Growth
  • MFC 9.27
  • KTTA N/A
  • 52 Week Low
  • MFC $23.30
  • KTTA $0.67
  • 52 Week High
  • MFC $33.07
  • KTTA $7.50
  • Technical
  • Relative Strength Index (RSI)
  • MFC 40.45
  • KTTA 32.67
  • Support Level
  • MFC $30.44
  • KTTA $0.67
  • Resistance Level
  • MFC $30.90
  • KTTA $0.77
  • Average True Range (ATR)
  • MFC 0.51
  • KTTA 0.04
  • MACD
  • MFC -0.14
  • KTTA 0.01
  • Stochastic Oscillator
  • MFC 11.46
  • KTTA 14.02

About MFC Manulife Financial Corporation

Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: